Atlas Trials

Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB

Clinical trial NCT04491604 · COMPLETED

Trial details

NCT number
NCT04491604
Sponsor
Krystal Biotech, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis Bullosa
Start date
2020-08-17
Primary completion
2021-10-29
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.